Shares of AngioDynamics ( ANGO -4.24%) were crashing 17.1% lower as of 10:43 a.m. ET on Thursday. The steep sell-off came ...

Throughout the last three months, 4 analysts have evaluated AngioDynamics ANGO -7.14% Get Free Report , offering a diverse ...

Q1 2025 Earnings Call Transcript October 3, 2024 AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.11, ...

AngioDynamics, Inc. ANGO reported an adjusted loss per share of 11 cents for first-quarter fiscal 2025, against the year-ago ...

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on AngioDynamics (ANGO – Research Report) today and set a price target of $14.00.

Analysts expect the Latham, New York-based company to report a quarterly loss at 15 cents per share, versus a year-ago loss ...

For the full year, AngioDynamics expects net sales to be in the range of $282 to $288 million, and adjusted loss per share of between $0.38 and $0.42. Analysts expect the company to report a loss of ...

AngioDynamics expects full-year earnings in the range of 38 cents to 42 cents per share, with revenue in the range of $282 million to $288 million. AngioDynamics shares have decreased slightly more ...

AngioDynamics swung to a loss in its fiscal first quarter, although better than feared, and said it continues to expect sales growth in fiscal 2025.

For the year, the company backed its outlook for sales of between $282 million and $288 million and an adjusted loss between 42 cents a share and 38 cents a share. Analysts surveyed by FactSet are ...

AngioDynamics Inc (NASDAQ:ANGO) is set to release its Q1 2025 earnings on Oct 3, 2024.The consensus estimate for Q1 2025 revenue is $67.93 million, and the earnings are expected to come in at -$0. ...

AngioDynamics (ANGO) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through ...